TOP

LOGIN
Critical Illness Insights – Malaysia

Critical Illness (CI) insurance was introduced to Malaysia in the late 1980s. The popularity of CI products gained momentum during the 1990s and 2000s. Malaysia, a diverse market, has both Takaful and non-Takaful CI products. Experiences coming through from these products are different, with non-Takaful products having a higher proportion of cancer claims. Our study counts Malaysia as its core market since the 1990s and can identify risk and emerging trends for the market.

The infographic below summarises the latest Dread Disease Survey results for the Malaysia market. For more information about the result, please contact the CI Insights team.

Malaysia Critical Illness Data Insights
Publication
Malaysia Critical Illness Data Insights 2019–2024: Key Takeaways for the Market [Infographic]
The Malaysia CI insurance market has grown steadily, with more people buying coverage early in life. Claims are showing an increase in early-stage illnesses and older claimants. Cancer remains a leading cause for women, while heart disease is prominent for men, highlighting evolving health risks.
Samuel Lim, Wendy Low August 20, 2026
Read More
Publication
Insights from Gen Re’s Dread Disease Survey for the Hong Kong, Malaysia, and Singapore Markets
The 8th edition of Gen Re’s Dread Disease Survey has been released for the Hong Kong, Malaysia and Singapore markets. This survey captures new insights into the prevalence, incidence, and impact of Critical Illness (CI). We present key findings from the three markets.
Orchis Li December 5, 2023
Read More
RELATED CONTENT

Critical Illness in Asia – Product Evolution and its Implications

Critical Illness Insights – Mainland China

Critical Illness Insights – Hong Kong

Critical Illness Insights – Singapore

Critical Illness Insights – Thailand